Document Detail


Update on the Use of Biologics in Lupus.
MedLine Citation:
PMID:  25091119     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Systemic lupus erythematosus is more than a heterogeneous autoimmune disease. It is in fact a syndrome of many different clinical genotypes and phenotypes. This review covers the most recently studied monoclonal antibodies and those currently being investigated. The key trials are summarized, including those for biologics on the market for two decades and those just approved for lupus less than two years ago. The focus will be on the following four: Rituximab, Abatacept, Belimumab, and Epratuzumab. It is a challenge to design the perfect trial and study patients with this disease as each has his or her own unique manifestations, biological markers, and underlying genetic background. However, as our understanding of the immune mechanisms involved in lupus increases; novel therapies will emerge that can be utilized for appropriately selected patients.
Authors:
Manisha Relan; Sahana Vishwanath; Long Shen; Julian L Ambrus
Related Documents :
20199469 - Niemann-pick disease in association with syringocystadenoma papilliferum.
21315399 - Physical therapy assessment tools to evaluate disease progression and phenotype variabi...
24786579 - Ultrastructural examination of a case of pagetoid bowen disease exhibiting immunohistoc...
23489309 - Diagnostic biomarkers in multiple sclerosis.
19548379 - Initial anatomic geographic presentation of glottal dysplasia.
23515049 - A human monoclonal antibody against the collagen type iv α3nc1 domain is a non-invasive...
6146959 - The chronic bronchitis complex in children.
16293159 - A case study: identifying a new case of wilson's disease.
24398179 - The epidemiology of dietary antioxidants and atherosclerotic disease.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-8-04
Journal Detail:
Title:  Current pharmaceutical biotechnology     Volume:  -     ISSN:  1873-4316     ISO Abbreviation:  Curr Pharm Biotechnol     Publication Date:  2014 Aug 
Date Detail:
Created Date:  2014-8-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100960530     Medline TA:  Curr Pharm Biotechnol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Applications of Lipid Based Formulation Technologies in the Delivery of Biotechnology-Based Therapeu...
Next Document:  Determination of the elastic properties of short ssDNA molecules by mechanically folding and unfoldi...